Press release -
Cavidi joins UIC Business Accelerator
Uppsalla, Sweden
Cavidi, leading Swedish HIV companion diagnostic supplier, joins Uppsala Innovation Centre (UIC), a business incubator for growth companies in the Uppsala region. The Business Accelerator Program will support Cavidi’s next expansion phase of the company including the launch of a new automated HIV-monitoring platform. Cavidi aims to grow its development activity, production capacity, and distribution reach in order to harness the expansion of the HIV monitoring market - expected to be worth over 1 billion USD by 2020.
For more information about the UIC Business Accelerator please refer to http://www.uic.se/index.php?page=eng-business-accelerator
About Cavidi
Cavidi is Sweden’s leading supplier of companion diagnostics for HIV monitoring. Cavidi’s products enable efficient management of anti-HIV drugs (ARV therapy) so that people living with HIV can live a normal lifespan. Cavidi’s companion diagnostics reduce the cost of treatment and the spread of HIV. Cavidi is a Swedish biotech company with its head office in Uppsala and sales offices in South Africa, India and USA. Cavidi won the Swecare Export Award 2012. www.cavidi.com
About Uppsala Innovation Centre
With its well-documented successes, Uppsala Innovation Centre (UIC) is one of Sweden’s top business incubators. Nine out of ten UIC alumni companies remain active in the market today. UIC offers the qualified advice and support essential for a successful business venture – not to mention a large and active network of key contacts. Our goal is to secure the development of more viable growth companies with high rates of survival. We support business owners, entrepreneurs, innovators, researchers and growth companies in their efforts to commercialize their ideas and develop their business acumen. The UIC model includes six development programs and 50 selected business coaches from the commercial and industrial sectors, all focused on helping companies achieve their stated goals. UIC is industry-independent and does not take any ownership interest in the companies. UIC has operations in Uppsala, Östhammar and Södertälje. UIC is owned in equal parts by the STUNS foundation, Uppsala municipality, SLU Holding AB and Uppsala University Holding AB. Uppsala Innovation Centre is part of Almi Företagspartner’s incubator program Business Incubation for Growth Sweden (B.I.G. Sweden).
Topics
- Medical research
Categories
- sweden
- innovation
- hiv
- health care
- cavidi
For over two decades Cavidi has been dedicated to increasing access to HIV viral load monitoring for all HIV-positive patients. Our ExaVir™ Load test accomplishes this by bringing national reference lab quality to the nearpatient environment. Independent studies confirm that ExaVir Load is as accurate as gold standard RNA-based tests yet is capable of running in virtually any lab. In fact, ExaVir Load is proven to perform at the District Hospital level where the need is greatest.
To date, over 350,000 ExaVir Load tests have been run backed by governments and major global NGOs in more than 25 countries. But there is still much work to be done. Cavidi is committed to continued innovation in this area in support of our conviction that the time for HIV viral load testing is now
